You are here: Industry Insights > new treatment

News List

FDA Approves New Treatment for Pediatric Patients with Type 2 Diabetes americanpharmaceuticalreview
June 20, 2019
The U.S. Food and Drug Administration (FDA) approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved to treat type 2 diabetes in pediatric patients
ALS Organizations Collaborate to Advance New Therapeutic into Trials pharmafocusasia
December 03, 2018
Several ALS organizations announced on Wednesday that the first participant was successfully given a dose of AT-1501 in the first in-human trial of the potential treatment for ALS.
FDA Approves New Treatment for Rare Genetic Disorder americanpharmaceuticalreview
August 14, 2018
The U.S. Food and Drug Administration (FDA) approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.
FDA approves new treatment for rare adrenal gland tumours europeanpharmaceuticalreview
August 06, 2018
The US Food and Drink Administration (FDA) approved an injection for the treatment of a rare adrenal gland tumour in adolescents and adults.
FDA Approves New Treatment for Ulcerative Colitis drugs
May 31, 2018
U.S. Food and Drug Administration approval of Xeljanz (tofacitinib) has been expanded to include adults with active moderate-to-severe ulcerative colitis, the agency said Wednesday.